-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Opiant Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
CRYSTAL ROGER
CEO |
Sell | 1,358 @ $20.26 | $27,513 | 75,339 | 01/27/2023 | 01/31/2023 | |
|
Ellison Mark Jason Heath
Chief Development Officer |
Sell | 610 @ $20.26 | $12,359 | 18,751 | 01/27/2023 | 01/31/2023 | |
|
Gorman Brian
Director |
Sell | 444 @ $20.26 | $8,995 | 31,990 | 01/27/2023 | 01/31/2023 | |
|
Skolnick Phil
Chief Scientific Officer |
Sell | 480 @ $20.26 | $9,725 | 21,548 | 01/27/2023 | 01/31/2023 | |
|
O'Toole David D
CFO |
Sell | 541 @ $20.26 | $10,961 | 34,248 | 01/27/2023 | 01/31/2023 | |
|
O'Toole David D
CFO |
Sell | 415 @ $20.20 | $8,383 | 34,789 | 01/09/2023 | 01/09/2023 | |
|
Ellison Mark Jason Heath
Chief Development Officer |
Sell | 469 @ $20.20 | $9,474 | 19,361 | 01/09/2023 | 01/09/2023 | |
|
Skolnick Phil
Chief Scientific Officer |
Sell | 369 @ $20.20 | $7,454 | 22,028 | 01/09/2023 | 01/09/2023 | |
|
CRYSTAL ROGER
CEO |
Sell | 1,183 @ $20.20 | $23,897 | 76,697 | 01/09/2023 | 01/09/2023 | |
|
Ellison Mark Jason Heath
Chief Development Officer |
Sell | 1,806 @ $20.20 | $36,481 | 19,830 | 01/05/2023 | 01/05/2023 | |
|
O'Toole David D
CFO |
Sell | 1,600 @ $20.20 | $32,320 | 35,204 | 01/05/2023 | 01/05/2023 | |
|
Gorman Brian
Director |
Sell | 1,313 @ $20.20 | $26,523 | 32,434 | 01/05/2023 | 01/05/2023 | |
|
Skolnick Phil
Chief Scientific Officer |
Sell | 1,421 @ $20.20 | $28,704 | 22,397 | 01/05/2023 | 01/05/2023 | |
|
CRYSTAL ROGER
CEO |
Sell | 5,029 @ $20.20 | $101,586 | 77,880 | 01/05/2023 | 01/05/2023 |